Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-12-12
Summary
The overarching aim of this study is to investigate the contribution of peripheral afferent input to spontaneous and evoked central neuropathic pain after a spinal cord lesion or disease.
Conditions
- Spinal Cord Injuries
- Spinal Cord Diseases
- Syringomyelia
Interventions
- DIAGNOSTIC_TEST
-
Lidocaine (10 mg/ml)
Lidocaine (10 mg/ml) will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.
- DIAGNOSTIC_TEST
-
Isotonic saline
Isotonic saline will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Jan Rosner, MD · Danish Pain Research Center, Department of Clinical Medicine, Aarhus University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-09-30
- Completion
- 2023-12-31
More Related Trials
-
Ear Acupuncture for Neuropathic Pain
NCT05052645 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacological Modulation of Peripheral Nerve Excitability
NCT06312254 ·Status: COMPLETED ·Phase: NA
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
NCT04533919 ·Status: WITHDRAWN
-
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
NCT01112748 ·Status: COMPLETED ·Phase: PHASE4
-
Intrathecal Ziconotide Antalgic Efficacy for Severe Refractory Neuropathic
NCT03942848 ·Status: UNKNOWN ·Phase: PHASE3
-
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
NCT00058357 ·Status: COMPLETED ·Phase: PHASE3
-
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
NCT00258622 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Objective Assessment of Sensory Nerve Fiber Sensitivity
NCT03596489 ·Status: COMPLETED
-
Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain
NCT02597257 ·Status: UNKNOWN ·Phase: PHASE2
-
Injection Therapy for Neuropathic Pain
NCT05809700 ·Status: COMPLETED ·Phase: NA
-
The Significance of Peripheral Input
NCT04764045 ·Status: UNKNOWN ·Phase: NA
-
Conus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia
NCT02564172 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.
NCT02137954 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820 ·Status: COMPLETED
-
Oral LAT8881 in Neuropathic Pain
NCT03865953 ·Status: COMPLETED ·Phase: PHASE2
-
Burst Spinal Cord Stimulation for Neuropathic Pain.
NCT03733886 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Injection Techniques in Celiac Plexus Neurolysis
NCT02068677 ·Status: COMPLETED ·Phase: NA
-
Excitability Protocol: Voltage-gated Ion Channels
NCT05368532 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
NCT02100956 ·Status: TERMINATED ·Phase: PHASE2
-
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
NCT02217267 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING